Table 6B. Multiple logistic regression analysis for max-IMT in 453 subjects without lipid lowering therapy.
Without lipid lowering therapy (n = 453) |
||||
---|---|---|---|---|
variables | OR | 95%CI | p | |
Age | 1.127 | 1.087 | 1.168 | <0.0001 |
Gender* | 0.341 | 0.200 | 0.583 | 0.0001 |
HDL3-C | 0.950 | 0.890 | 1.015 | 0.129 |
HDL2-C | 1.008 | 0.992 | 1.025 | 0.338 |
LDL-C | 1.010 | 1.002 | 1.018 | 0.016 |
LogTG | 1.790 | 0.535 | 5.994 | 0.345 |
BMI | 1.010 | 0.940 | 1.085 | 0.780 |
DBP | 1.002 | 0.980 | 1.024 | 0.890 |
HbA1c (NGSP) | 1.364 | 0.855 | 2.177 | 0.193 |
eGFR | 1.018 | 1.003 | 1.034 | 0.018 |
Alcohol habits | 0.604 | 0.357 | 1.021 | 0.060 |
Smoking | 0.244 | 0.090 | 0.664 | 0.006 |
Exercise | 1.037 | 0.680 | 1.581 | 0.867 |
A dichotomous variable according to max-IMT (i.e., max-IMT ≧1.5 mm vs. <1.5 mm) was examined in the analysis.
OR: odds ratio, 95%CI: 95% confidence interval,
1: men, 2: women